Literature DB >> 12471461

Expression of extracellular matrix components in a highly infiltrative in vivo glioma model.

Rupavathana Mahesparan1, Tracy-Ann Read, Morten Lund-Johansen, Kai Ove Skaftnesmo, Rolf Bjerkvig, Olav Engebraaten.   

Abstract

This work demonstrates the expression of extracellular matrix (ECM) components in a highly infiltrative brain tumor model developed by simple inoculation of spheroids from five human glioma biopsy tissues directly into the brains of immunodeficient rats. Non-invasive tumors derived from one glioblastoma biopsy specimen and two glioma cell lines (D-54MG and U-251MG) were also included in this study. The extent of tumor cell infiltration was studied using a pan-human monoclonal anti-vimentin antibody. The cellular origin for several of these ECM components was identified using human-specific monoclonal antibodies and polyclonal antibodies detecting epitopes from both species. Immunostaining revealed a diffuse parenchymal staining of glioma-produced tenascin, whereas vitronectin was produced mainly by the invading glioma cells. ECM components such as laminin, fibronectin and collagen type IV were most probably produced by the host and were mainly associated with the blood vessels in the tumors. However, some parenchymal staining with regional variations was observed. The expression pattern of these components was different in cell lines tumors as compared to the biopsy specimen tumors. The alpha3 and beta1 integrin subunits were mainly observed in areas of tumor cell invasion in the invasive tumors. In conclusion, the observed staining patterns clarify the cellular origin and indicate the possible biological function of tenascin, vitronectin, laminin, fibronectin and collagen type IV in these highly invasive malignant tumors of glial origin.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12471461     DOI: 10.1007/s00401-002-0610-0

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  64 in total

1.  The mechanical and pharmacological regulation of glioblastoma cell migration in 3D matrices.

Authors:  Pranita Kaphle; Yongchao Li; Li Yao
Journal:  J Cell Physiol       Date:  2018-08-21       Impact factor: 6.384

2.  Regulatory effect of nerve growth factor in alpha9beta1 integrin-dependent progression of glioblastoma.

Authors:  Meghan C Brown; Izabela Staniszewska; Philip Lazarovici; George P Tuszynski; Luis Del Valle; Cezary Marcinkiewicz
Journal:  Neuro Oncol       Date:  2008-12       Impact factor: 12.300

3.  Modulation of hyaluronan production by CD44 positive glioma cells.

Authors:  Marzenna Wiranowska; Sharron Ladd; Lynn C Moscinski; Bobbye Hill; Ed Haller; Katalin Mikecz; Anna Plaas
Journal:  Int J Cancer       Date:  2010-08-01       Impact factor: 7.396

4.  Age-Dependent Association between Protein Expression of the Embryonic Stem Cell Marker Cripto-1 and Survival of Glioblastoma Patients.

Authors:  Berit B Tysnes; Hege A Satran; Sverre J Mork; Naira V Margaryan; Geir E Eide; Kjell Petersen; Luigi Strizzi; Mary J C Hendrix
Journal:  Transl Oncol       Date:  2013-12-01       Impact factor: 4.243

5.  Meta-analysis of glioblastoma multiforme versus anaplastic astrocytoma identifies robust gene markers.

Authors:  Jonathan M Dreyfuss; Mark D Johnson; Peter J Park
Journal:  Mol Cancer       Date:  2009-09-04       Impact factor: 27.401

6.  MMP-9, uPAR and cathepsin B silencing downregulate integrins in human glioma xenograft cells in vitro and in vivo in nude mice.

Authors:  Krishna Kumar Veeravalli; Chandramu Chetty; Shivani Ponnala; Christopher S Gondi; Sajani S Lakka; Daniel Fassett; Jeffrey D Klopfenstein; Dzung H Dinh; Meena Gujrati; Jasti S Rao
Journal:  PLoS One       Date:  2010-07-15       Impact factor: 3.240

7.  Osteopontin regulates human glioma cell invasiveness and tumor growth in mice.

Authors:  Hsun-Jin Jan; Chin-Cheng Lee; Yung-Luen Shih; Dueng-Yuan Hueng; Hsin-I Ma; Jing-Huei Lai; Hen-Wei Wei; Horng-Mo Lee
Journal:  Neuro Oncol       Date:  2009-12-23       Impact factor: 12.300

8.  Remission of invasive, cancer stem-like glioblastoma xenografts using lentiviral vector-mediated suicide gene therapy.

Authors:  Peter C Huszthy; Tsanan Giroglou; Oleg Tsinkalovsky; Philipp Euskirchen; Kai Ove Skaftnesmo; Rolf Bjerkvig; Dorothee von Laer; Hrvoje Miletic
Journal:  PLoS One       Date:  2009-07-20       Impact factor: 3.240

9.  A reproducible brain tumour model established from human glioblastoma biopsies.

Authors:  Jian Wang; Hrvoje Miletic; Per Ø Sakariassen; Peter C Huszthy; Hege Jacobsen; Narve Brekkå; Xingang Li; Peng Zhao; Sverre Mørk; Martha Chekenya; Rolf Bjerkvig; Per Ø Enger
Journal:  BMC Cancer       Date:  2009-12-29       Impact factor: 4.430

10.  iTRAQ-based proteomics profiling reveals increased metabolic activity and cellular cross-talk in angiogenic compared with invasive glioblastoma phenotype.

Authors:  Uros Rajcevic; Kjell Petersen; Jaco C Knol; Maarten Loos; Sébastien Bougnaud; Oleg Klychnikov; Ka Wan Li; Thang V Pham; Jian Wang; Hrvoje Miletic; Zhao Peng; Rolf Bjerkvig; Connie R Jimenez; Simone P Niclou
Journal:  Mol Cell Proteomics       Date:  2009-08-12       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.